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SUMMARY 
Glucose-sensing neurons in the brainstem participate in the regulation of energy homeostasis but 
have been poorly characterized because of the lack of specific markers to identify them. Here we 
show that Glut2-expressing neurons of the nucleus of the tractus solitarius form a distinct 
population of hypoglycemia-activated neurons. Their response to low glucose is mediated by 
reduced intracellular glucose metabolism, increased AMP-activated protein kinase activity, and 
closure of leak K+ channels. These are GABAergic neurons that send projections to the vagal 
motor nucleus. Light-induced stimulation of channelrhodospin-expressing Glut2-neurons in vivo 
led to increased parasympathetic nerve firing and glucagon secretion. Thus Glut2-neurons of the 
nucleus tractus solitarius link hypoglycemia detection to counterregulatory response. These 
results may help identify the cause of hypoglycemia associated autonomic failure, a major threat 
in the insulin treatment of diabetes. 
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HIGHLIGHTS 
• Glucose transporter Glut2 defines a subpopulation of glucose-sensing neurons in NTS 
• NTS Glut2 neurons are excited when glucose levels drop 
• Glucose sensing involves leak K+ channels, cellular glucose metabolism and AMPK 
• Glut2 neurons are GABAergic cells controlling vagal output and glucagon secretion 
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INTRODUCTION 
Feeding, energy expenditure, and glucose homeostasis are processes that are regulated by 
many signals reflecting the metabolic status of the organism. Nutrients, including glucose, lipids 
and amino acids, play a particularly important role in orchestrating these responses by directly 
controlling the secretion of hormones such as insulin and glucagon, and by modulating the 
activity of the autonomic nervous system to coordinate the adaptation of peripheral organs to 
changes in energy metabolism (Schwartz et al., 2000; Thorens, 2012).  
Glucose-sensing neurons have been identified and classified in two major categories, glucose 
excited (GE) and glucose inhibited (GI), depending on the effect of extracellular glucose on their 
firing activity (Routh, 2002). There is evidence for a large diversity in the mechanisms of 
neuronal glucose-sensing and for their wide topographical distribution (Thorens, 2012). It is 
established that the hypothalamus and brainstem are important centers that integrate nutrient, 
hormonal and nervous signals controlling energy metabolism. Evidence has been provided that 
NPY and POMC neurons in arcuate nucleus (AN), MCH and orexin neurons of the lateral 
hypothalamus (LH), as well as a large number of neurons from the ventromedial hypothalamus 
(VMH) are glucose-responsive and may control adaptive responses to hypo- or hyperglycemia 
(Gonzalez et al., 2009; Kang et al., 2004; Parton et al., 2007). In the brainstem, the dorsal vagal 
complex (DVC), which consists in the area postrema (AP), the nucleus of the tractus solitarius 
(NTS), and the dorsal motor nucleus of the vagus (DMNX), also contains GE and GI neurons 
(Balfour et al., 2006; Balfour and Trapp, 2007). These neurons are involved in various 
glucoregulatory functions, including the stimulation of feeding and glucagon secretion in 
response to hypoglycemia and the increase of insulin secretion in response to hyperglycemia 
(Marty et al., 2005; Marty et al., 2007; Ritter et al., 2000). They also control gastric motility 
(Ferreira et al., 2001; Grill and Hayes, 2012). Although there is abundant evidence for the 
presence of glucose-sensing neurons in brainstem, the lack of specific markers hampers a clear 
identification of these cells and any further characterization of their molecular mechanisms of 
glucose detection, and of the neuronal circuits in which they are integrated.  
In previous studies we reported that expression of the glucose transporter Glut2 in the brain 
is required for several glucoregulatory responses, including glucagon secretion (Marty et al., 
2005), feeding (Bady et al., 2006), and thermoregulation (Mounien et al., 2010). Using a genetic 
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reporter system we showed that Glut2-expressing neurons were scattered in different 
hypothalamic nuclei, including the LH, VMH, paraventricular hypothalamus and the zona incerta 
(Mounien et al., 2010). In the AN, Glut2-expressing nerve terminals were found in contact with 
NPY and POMC neurons, which did not express themselves this gene. Glut2 neurons were also 
found in brainstem, in particular in the DVC. In this structure, neuroglucopenia activated c-fos 
expression in Glut2 cells, suggesting that they are GI neurons (Mounien et al., 2010). More 
recently, we showed that Glut2 inactivation in the nervous system (NG2KO mice) led to 
suppressed regulation by glucose of the parasympathetic and sympathetic nerve activity. This 
caused impaired proliferation of beta-cells during the weaning period, reduced adult beta-cell 
mass, suppression of first phase insulin secretion, and progressive development of glucose 
intolerance. When NG2KO mice were fed a high fat diet, glucose intolerance developed faster 
and glucagon secretion became deregulated (Tarussio et al., 2014). Thus, Glut2-expressing cells 
in the nervous system are involved in the control by glucose of the autonomic nervous activity, 
which controls endocrine pancreas development and function. However, the specific role of 
Glut2-neuron subpopulations present in different hypothalamic and brainstem nuclei is not yet 
defined. 
Here, we report the electrophysiological properties of Glut2-neurons of the NTS, which form 
a homogeneous population of GI neurons mechanistically dependent on intracellular glucose 
metabolism, AMP-Kinase and activation of a leak K+ current. Furthermore, we find that these 
neurons are GABAergic interneurons sending projections to the DMNX. We show that when 
activated by optogenetic tools, they increase parasympathetic activity and stimulate glucagon 
secretion, thus defining a neuronal circuit linking hypoglycemia detection to counterregulatory 
response. 
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RESULTS 
Glut2 Cells Are Glucose-Sensing Neurons Excited by Low Glucose Levels  
To identify Glut2-expressing cells in brainstem, we crossed Glut2-Cre mice (Mounien et al., 
2010) with a Rosa26tdTomato reporter line (Madisen et al., 2010). We observed clusters of 
tdTomato-positive (tdT+) cells in the NTS of resulting animals (Figure 1A). These cells were 
more frequently found in the caudal and dorsal aspects of the NTS, in agreement with existing 
reports on the anatomical localization of Glut2 cells in the brainstem (Arluison et al., 2004). 
They appeared as multipolar neurons with extensive projections in and outside from NTS 
(Figure 1A). We performed whole-cell patch-clamp recordings in acute brainstem slices to 
analyze their electrophysiological properties (Figure 1A and Table S1). TdT+ cells were not 
spontaneously active, however, they fired accommodating spike trains when stimulated by 
depolarizing current injection (Figure 1B). Single-cell RT-PCR (scRT-PCR) amplification 
performed on cytosols collected at the end of electrophysiological recordings detected expression 
of Glut2 in 67% of tdT+ cells (Figure 1C). The failure to detect Glut2 in every cell we attribute 
to the low levels of expression of this gene (Arluison et al., 2004) and the low sensitivity of 
scRT-PCR. Because of this and the absence of Glut2 detection in all tested tdT- cells (not shown), 
we concluded that the tdTomato reporter system selectively labeled Glut2-expressing cells. 
 We assessed whether Glut2 neurons sensed extracellular glucose level by recording their 
electrical properties while changing glucose concentration in the superfusion buffer. Switching 
from 5 to 0.5mM glucose produced a reversible increase in resting membrane potential (Vm) of 
6.7±1.0mV (p<2 x 10-5, n=13) and in input resistance (Rinput) of 451±75MΩ (p<6 x 10-5, n=13) 
(Figure 1D-E). This glucose response pattern was observed consistently in all the tdT+ cells we 
recorded (n=25). By contrast, neighboring tdT- neurons were unresponsive to a similar change in 
glucose concentration (ΔVm=-0.2±0.4mV, p>0.53, n=5; ΔRinput=-129±133MΩ, p>0.38; n=5), 
indicating that this effect is specific to Glut2 cells (Figure S1A-B). The response of tdT+ 
neurons to glucose was not altered when experiments where repeated in the presence of 
inhibitors of synaptic transmission (ΔVm=5.5±1.0mV, p<0.0002, n=12; ΔRinput=395±79MΩ, 
p<0.0004, n=12), demonstrating a cell-autonomous effect (Figure 1D-E).  
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To test the impact of glucose-dependent variations in resting membrane properties on cell 
excitability, we injected depolarizing current steps and plotted the observed firing rates as a 
function of injected current intensity (FI curve). Switching from 5mM to 0.5mM glucose 
increased the firing frequency for the same amount of current injected (Figure 1F), leading to an 
increase in the slope of the FI curve (FI gain) of 0.082±0.020 Hz/pA (p<0.0025, n=10; Figure 
1F-G). This increase in excitability was confirmed by a decrease in the minimal amount of 
current required to trigger action potentials (Rheobase) of 30.8±9.4pA (p<0.0073, n=12; Figure 
1G). The absence of any glucose effect on single action potential and spike train properties 
(Table S2) indicated that changes in excitability were only due to alterations of passive 
membrane properties. Experiments performed in the presence of synaptic blockers yielded 
similar changes in FI gain (ΔFI gain=0.141±0.038 Hz/pA, p<0.0047, n=10) and rheobase 
(ΔRheobase=-16.4±5.7 pA, p<0.016, n=12) than without inhibitors (Figure 1G), confirming that 
lowering glucose increased cell excitability independently from neuronal network activity.  
We further determined that passive membrane properties and indices of cell excitability (FI 
gain and rheobase) changed monotonically with intermediate glucose concentrations (Figure 
1H). Thus, Glut2 neurons reliably detect glucose changes for typical concentrations found in 
brain extracellular medium (Dunn-Meynell et al., 2009; Silver and Erecinska, 1994). 
To exclude that the whole-cell approach used so far could affect cell responses by altering 
the concentration of intracellular metabolites and other regulatory factors, we performed cell-
attached recordings to monitor cell excitability without interfering with cell content. Action 
potential firing increased by 2.3 fold (p<0.0039, n=6) when glucose concentration was lowered 
from 5 to 0.5mM, in the presence of synaptic blockers (Figure S1C-D), ruling out any 
significant effect of the recording procedure on the response of Glut2 neurons to glucose. 
 
Leak Potassium Channels Drive the Glucose Response of Glut2 Neurons 
We further investigated ionic conductances underlying glucose-induced inhibition in Glut2 
neurons. The cell depolarization paired with Rinput increase under lowered glucose (Figure 1D-E), 
suggested a mechanism involving the closure of a conductance for hyperpolarizing ions. Under 
recording conditions used in these experiments, calculated equilibrium potential for main ion 
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species present indicated that only K+ (EK=-101mV) and Cl- (ECl=-75mV) currents would reverse 
at more hyperpolarized values than the resting membrane potential. We therefore acquired 
current-voltage (IV) relationships at different glucose concentrations. Switching glucose from 
5mM to 0.5mM resulted in a reversible decrease in the IV curve slope (Figure 2A), 
corresponding to an increase of 323±68 MΩ in Rinput (p<6.4x10-4, n=12) in agreement with the 
change measured by periodic current pulse injection during continuous voltage recordings. In 
addition, IV curves showed that whole-cell currents varied monotonically with glucose 
concentration with the same non-linear dependency than cell properties measured previously 
(Figure S2A). Net glucose-induced current was calculated as the difference between current 
values measured at 5mM and 0.5mM. IV curve of net glucose current showed a reversal 
potential of -95.5±2.0mV, indicating a conductance selective for K+ (Figure 2A). Moreover, this 
IV curve had an outward rectifying trend well described by the Goldman-Hodgkin-Katz (GHK) 
current equation (Figure 2A), which pointed to a leak K+ channel (Burdakov et al., 2006). The 
kinetics of net glucose-induced currents during voltage steps, consisting in a fast activation and 
an absence of decay over time (Figure 2A), are further attributes in favor of a leak K+ 
conductance (Burdakov et al., 2006). The shape of net glucose current IV curve clearly excluded 
a voltage-gated K+ channel or an inward rectifying K+ channel. Calcium-dependent K+ channels 
were unlikely to contribute to glucose effect since no changes in AHP and spike frequency 
adaptation were observed (Table S2).  
To confirm the nature of the conductance responsible for the glucose effect, we performed 
recordings using a pipette solution with elevated Cl- in order to shift the calculated equilibrium 
potential of this ion to a value more depolarized than resting membrane potential (ECl=0mV). In 
this condition, if Cl- channels were involved, their opening at 5mM glucose would lead to an 
excitatory effect while decreasing glucose would result in inhibition. Instead, switching from 
5mM to 0.5mM glucose produced a depolarization (ΔVm=9.8±1.3mV, p<1.9x10-5, n=11; Figure 
2B,D) and an increase in cell excitability (ΔFI gain=0.132±0.041 Hz/pA, p<0.0047, n=9; 
ΔRheobase=-51.9±17.3 pA, p<0.016, n=9; Figure 2D) similar to the ones obtained with low 
pipette Cl-, supporting the sole implication of K+ channels. Continuous recording of glucose-
induced current with high intrapipette Cl- in the presence of tetrodotoxin unveiled an outward 
current of 18.6±4.5 pA consistent with the closure of a K+ conductance (Figure 2C). In 
agreement with the implication of leak K+ channels, net glucose-induced current displayed an 
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outward rectification and reversed at a similar value than with low Cl- intracellular solution 
(Erev=-103.8±3.6mV, p>0.066; Figure S2B).  
We also pharmacologically probed the ionic mechanism of glucose effect. Bath application 
of leak K+ channel blocker quinine (200 µM) produced an increase in Vm (ΔVm=12.4±2.2mV, 
p<0.003, n=6) and Rinput (ΔRinput=506±172 MΩ, p<0.033, n=6; Figure 2E-F) and an inward shift 
of the IV curve (Figure S2C) indicative of the closure of a hyperpolarizing resting conductance. 
The quinine-inhibited current, obtained by subtracting currents before and after quinine 
application, was outward rectifying, reversed at -97.5±2.8mV and was fitted by the GHK current 
equation (r2=0.98) (Figure S2C), confirming the expression of functional leak K+ channels by 
NTS Glut2 neurons at rest. Furthermore, quinine prevented electrophysiological changes induced 
by lowering glucose concentration, (ΔVm=1.5±1.2mV, p<0.27; ΔRinput=72±36 MΩ, p<0.11, n=6; 
Figure 2E-F), showing that leak K+ channels are required for the glucose response.  
 
Glucose Metabolism Is Required for Glucose Sensing by Glut2 Neurons 
We next tested if changes in Glut2 neuron excitability depended on glucose metabolism. 
Superfusion of the metabolic inhibitor 2-deoxyglucose (2-DG, 10mM) in the presence of 5mM 
glucose induced an increase in Vm (ΔVm=6.8±1.1mV, p<0.003, n=5) and Rinput (ΔRinput=263±76 
MΩ, p<0.026, n=5; Figure 3A-B) that mimicked the changes in membrane properties observed 
when lowering extracellular glucose, indicating that integrity of glucose metabolic pathways is 
important for the effect of glucose on these neurons. We then tested whether superfusion of 
glucokinase competitive inhibitor D-glucosamine in the presence of high glucose would mimic 
the effect of glucoprivation on Glut2 neurons. D-glucosamine (10mM) produced similar changes 
on resting membrane properties than glucose depletion (ΔVm=5.8±1.0mV, p<0.0014, n=7; 
ΔRinput=182±53 MΩ, p<0.014, n=7; Figure 3C-D), showing that the glucose-induced inhibition 
of Glut2 neurons depends on intracellular processing of glucose. Studies on glucose sensing 
mechanisms in other brain areas have reported direct effects of glucose on cell membrane 
without involvement of glucose metabolism (Gonzalez et al., 2009; O'Malley et al., 2006). To 
investigate whether glucose had a similar action on Glut2 neurons in NTS, we performed whole-
cell recordings with glucose present in the pipette. In this condition, where intracellular glucose 
Glut2 neurons control glucagon secretion  Lamy et al. 
 10 
metabolism is rendered independent from extracellular supply, responses to changes in 
extracellular glucose were abolished (ΔVm=-0.5±0.4mV, p>0.22, n=7; ΔRinput=-11±19 MΩ, 
p>0.59, n=7; Figure 3E-F). Nevertheless, adding D-glucosamine to these neurons still produced 
a glucoprivic pattern of membrane response (ΔVm=5.4±0.9mV, p<0.0014, n=6; ΔRinput=407±123 
MΩ, p<0.022; n=6; Figure 3E-F), indicating that the presence of glucose in the pipette did not 
result in a non-specific blunting of cell responsiveness. These experiments confirmed that 
glucose sensing mechanism requires cellular glucose uptake and catabolism. 
 
Glucose Response Is Mediated by AMPK  
We hypothesized, in agreement with former results, that glucose effect on Glut2 neurons is 
mediated by changes in cellular energy levels. Inducing a cellular ATP depletion by the 
superfusion on mitochondrial ATPase inhibitor Oligomycin (12 µM) resulted in an increase in 
Vm (ΔVm=7.2±1.7mV, p<0.006, n=7) and Rinput (ΔRinput=474±102.3 MΩ, p<0.004, n=7; Figure 
4A-B) similar to the changes in membrane properties produced by low glucose levels, suggesting 
that a decrease of ATP supply is the main signal driving the response to glucoprivation.  
Because AMP-activated protein kinase (AMPK) is a key sensor of cellular energy levels 
activated by ATP depletion and it is known to play an important role in the central regulation of 
energy homeostasis (Lage et al., 2008), we looked at its implication in the response of Glut2 
neurons to glucose. Bath application of AMPK activator AICAR (500 µM) produced similar 
effects than glucoprivation (ΔVm=8.5±1.4mV, p<0.001; ΔRinput=411±129 MΩ, p<0.020, n=7; 
Figure 4C-D). In addition, AMPK inhibitor Compound C (150 µM) reversed the response to 
low glucose (ΔVm=-5.1±1.2mV, p<0.006; ΔRinput=-396±92 MΩ, p<0.005, n=7) and blocked 
glucose-dependent changes (ΔVm=-0.6±0.5mV, p<0.3; ΔRinput=27±57 MΩ, p<0.7, n=7; Figure 
4E-F). Finally, we detected the expression of AMPK by immunohistochemistry in 67.9 % of 
NTS Glut2 neurons (n=109, Figure 4G). Together, these results demonstrate that AMPK 
mediates glucose sensing in NTS Glut2 neurons.    
 
NTS Glut2 Neurons Are Inhibitory Cells Projecting to DMNX 
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We then performed immunohistochemistry to determine the nature of the Glut2-expressing 
cells. We observed that GAD67, a marker of GABAergic inhibitory neurons, was expressed in 
80% of tdT+ cells (n=110; Figure 5A). Glut2 neurons also frequently expressed parvalbumin 
(PV), a marker found in GABAergic cells subpopulations (Figure 5B). GABAergic projections 
from NTS were previously shown to drive DMNX responses to glycemic changes (Ferreira et al., 
2001). To check whether NTS Glut2 neurons project to DMNX, we filled them with biocytin 
during whole-cell recording and post-processed slices to reveal axonal projections of recorded 
cells with confocal microscopy. Co-immunostaining for choline acetyltransferase (ChAT) was 
used to localize DMNX cholinergic cells. Biocytin-filled axons from some of the NTS 
tdTomato-positive neurons we recorded could be followed down to DMNX (Figure 5C), with 
axons showing enlargements reminiscent of axonal boutons in this area (Figure 5C). This 
suggests that NTS Glut2 neurons provide GABAergic input to DMNX. 
 
NTS Glut2 Neurons Activate the Vagus and Glucagon Secretion In Vivo 
We sought to determine the role of Glut2 neurons in vivo. Because Glut2 neurons respond to 
low glucose levels and project to vagal motor neurons, we reasoned they may affect vagal output 
and drive the counterregulatory response to hypoglycemia. To test this hypothesis we used an 
optogenetics approach. We crossed Glut2-Cre mice with a Rosa26ChR2-YFP reporter line 
(Madisen et al., 2012) to express channelrhodopsin (ChR2) in Glut2 neurons. We recorded these 
cells by whole-cell patch-clamp in acute NTS slices to check the efficiency of ChR2 expression 
(Figure 6A). Blue light illumination (473 nm) induced a reversible photocurrent and action 
potential firing (Figure 6B and S3A). When using pulsed (10ms) illumination, the frequency of 
both photocurrents and action potentials increased with that of light pulses (Figure 6C and S3B-
C). In vivo optogenetic stimulations were performed in anesthetized mice while vagal activity 
was recorded. An optical fiber was positioned with a stereotaxic micromanipulator at the dorsal 
face of the NTS to deliver pulses of blue light (Figure 6D). Light stimulation induced a rapid 
increase of vagal firing rate in ChR2-expressing animals but not in Cre-/ChR2+ littermates 
(p<0.0001, 2-way anova, n=6; Figure 6E). Blood glucagon levels, measured shortly after the 
end of the stimulation, where significantly higher in ChR2-expressing animals as compared to 
Cre-/ChR2+ controls (glucagon=105.0±31.7, n=7 vs. 326.5±66.1 pg/ml, n=6, p<0.009; Figure 
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6F). No differences in basal glucagonemia existed between the 2 groups (glucagon=135.0±51.5, 
n=11 vs. 143.4±21.6 pg/ml, n=10, p<0.9; Figure 6F). These data evidence a role for NTS Glut2 
neurons in the control of the parasympathetic regulation of glucagon secretion.  
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DISCUSSION 
Our results establish that expression of the glucose transporter isoform Glut2 identifies a 
homogenous glucose-sensing neuronal subpopulation in the nucleus of the tractus solitarius. 
These Glut2 neurons are glucose-inhibited cells whose response depends on intracellular glucose 
metabolism-driven changes in permeability of background potassium channels; they are 
GABAergic inhibitory neurons. Optogenetic activation of these NTS Glut2 neurons activates 
parasympathetic nerve firing and glucagon secretion, suggesting that they play an important role 
in the counterregulatory response to hypoglycemia.  
Glucose-sensing neurons have been identified in several brain areas involved in the control 
of energy homeostasis and related behaviors (Thorens, 2012). In the dorsal vagal complex, about 
20% of neurons respond to glucose with either a GE or a GI pattern (Balfour et al., 2006; Yettefti 
et al., 1997). GI neurons in this structure use a variety of molecular mechanisms to couple 
hypoglycemia to changes in membrane excitability (Balfour and Trapp, 2007), indicating that 
they form a diverse population of glucose-responsive cells. Their precise topographical and 
functional characterization is however difficult to assess because of the absence of specific 
markers allowing their identification. In this study, we found Glut2 to consistently single out a 
specific population of GI neurons in NTS. This glucose transporter isoform was first described 
for its role in glucose sensing in pancreatic beta-cells leading to insulin secretion. Previous data 
suggested that it might hold a similar role in central glucose detection (Marty et al., 2005; 
Mounien et al., 2010) and in the control by glucose of the parasympathetic and sympathetic 
nervous activities (Tarussio et al., 2014). Here we provide evidence for the functional association 
of Glut2 with glucose-sensing in neurons. Whole-cell and cell-attached recordings showed that 
lowering glucose increased excitability of Glut2-expressing neurons, an effect relying on glucose 
metabolism, and on the subsequent closure of leak K+ channels. A mediator of this response is an 
increase in intracellular AMP/ATP ratio that activates AMP-kinase, as shown for the response of 
other GI neurons such as those of the VMH (Murphy et al., 2009).  
Membrane depolarization of GI neurons has been attributed to diverse mechanisms, 
including the reduction of Na+/K+ATPase activity (Balfour and Trapp, 2007), the AMP-kinase-
dependent inhibition of the CFTR chloride conductance (Murphy et al., 2009), or the closure of 
leak K+ channels (Balfour and Trapp, 2007; Burdakov et al., 2006). We show that NTS Glut2 
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neurons’ response to low glucose depends on a leak K+ channel. However, in contrast to NTS 
Glut2 neurons, leak K+ channel-driven glucoprivic signaling in LH orexin neurons does not 
require glucose uptake or metabolism, but a putative cell surface receptor (Gonzalez et al., 2009). 
Thus, hypoglycemia can use different signaling pathways to control the same membrane 
conductances.  
An important observation is that depolarization of Glut2 NTS neurons increased 
progressively as external glucose concentrations decreased below euglycemic-like levels, 
however within the physiological extracellular concentration range found in the brain. Thus, 
glucose-sensitive Glut2-expressing neurons are in a position to fine-tune NTS glucoregulatory 
responses over physiological glucose concentrations.  
 Numerous studies indicated that brainstem and NTS glucose-responsive neurons are 
involved in whole body glucoregulation, such as neuroglucopenia-induced counterregulation and 
stimulation of feeding (Briski and Marshall, 2000; Dunn-Meynell et al., 2009). It was also shown 
that NTS neurons were connected to pancreas-projecting DMNX neurons by retrograde labeling 
using pseudorabies viruses (Buijs et al., 2001). In addition, NTS stimulation evoked GABAergic 
synaptic activity in DMNX (Ferreira et al., 2001). Here we showed that optogenetic activation of 
GABAergic Glut2-neurons of the NTS led to increased activity of vagal nerve and glucagon 
secretion. Although it is not known whether optogenetic stimulation resumes in vivo activation 
patterns by hypoglycemia, these results strongly suggest that NTS Glut2 neurons participate to 
physiological glucoregulatory responses. 
 Activation of parasympathetic nerves by NTS GABA neurons is consistent, on the one 
hand, with our observation that NTS Glut2 neurons send projections into the DMNX and, on the 
other hand, with the demonstration that a sizeable fraction of the NTS GABAergic input to the 
DMNX activates vagal nerves through inhibition of local tonic inhibitory neurons (Babic et al., 
2011). The fact that hypoglycemia-induced parasympathetic activity stimulates glucagon 
secretion is well established (Berthoud et al., 1990; Patel, 1984). Parasympathetic activity 
triggers the initial counterregulatory response to hypoglycemia when blood glucose 
concentration falls below euglycemia whereas activation of sympathetic activity is triggered at 
lower glycemic levels (Taborsky and Mundinger, 2012). In previous studies we showed that 
hypoglycemia or 2-DG-induced neuroglucopenia induced differential glucagon secretion in 
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control and Glut2-null mice. Importantly, this differential response was observed at intermediate 
levels of hypoglycemia (2.5 mM) or following injections carefully selected doses of 2-DG. At 
lower glycemic levels (1 mM) or following injection of larger doses of 2-DG glucagon secretion 
was equally stimulated in control and knockout mice (Burcelin and Thorens, 2001; Marty et al., 
2005). We thus hypothesized that Glut2-dependent nervous glucose sensing was involved in the 
detection of small, physiological changes in glycemic levels, while other mechanisms, such as a 
direct stimulation of pancreatic α cell secretion, might take place during deeper hypoglycemia 
(Zhang et al., 2013). Our present data showing that NTS Glut2 neurons are GI neurons inducing 
glucagon secretion through activation of parasympathetic activity is in agreement with this 
previous hypothesis.  
Collectively, our study provides the functional characterization of a new class of glucose-
sensing neurons based on the expression of the Glut2 glucose transporter. They demonstrate that 
the NTS is indeed an important site for glucose sensing, in particular during development of 
hypoglycemia, which can be mobilized to induce glucagon secretion. This is an important step in 
elucidating the mechanisms controlling stimulated glucagon secretion in physiological 
conditions but also when this secretion becomes unresponsive to developing hypoglycemia, as 
associated with hypoglycemia associated autonomic failure (Cryer, 2006), a serious condition 
that limits insulin treatment of both type 1 and type 2 diabetes.  
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EXPERIMENTAL PROCEDURES 
Slice preparation 
Sagittal slices of brainstem, 200µm thick, containing NTS were cut in ice-cold extracellular 
solution with 10mM glucose using a vibratome and were maintained in an incubation chamber at 
room temperature until used. 
Electrophysiology 
Slices were placed in a submerged-type recording chamber and continuously superfused with 
extracellular solution at room temperature. TdTomato-expressing neurons were localized by 
confocal epifluorescence microscopy. Whole-cell recordings from visually identified neurons 
where obtained with borosilicate glass pipettes. Continuous recordings of Vm were used to 
monitor the effect of glucose and drugs. Hyperpolarizing current pulses were periodically 
injected to monitor Rinput. Step protocols were used for additional measurements of cell 
properties. Cell attached recordings were performed on slice superfused with an extracellular 
solution promoting spontaneous firing.  
Data analysis 
Electrophysiological data were analyzed with pClamp10 (Molecular Devices). Voltages were 
corrected for calculated liquid junction potentials. Pooled data were presented as mean ± SEM. 
Statistical analysis and curve fitting were done with Origin8.5 (OriginLab). Statistical testing 
was performed with paired and unpaired 2-tailed Student’s t tests unless stated otherwise. 
Differences were considered significant for p < 0.05 (* p<0.05; ** p<0.01; *** p<0.001, n.s., 
non significant).  
Single cell RT-PCR 
The single-cell content was aspirated with a patch pipette and expelled into an RNase free PCR 
tube for reverse transcription. We then performed two successive PCR rounds. The first round of 
used the cDNAs present in the reverse transcription reaction as template. The second round used 
10µl of the first PCR product as template. The products of the second PCR round were analyzed 
on agarose gel using ethidium bromide. 
Immunohistochemistry 
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Immunostaining were done on brainstem cryosections obtained from mice perfused with 4% 
paraformaldehyde. Sections were incubated with primary monoclonal antibodies against GAD67 
(MAB5406, Chemicon), PV (PV235, Swant), pAMPK (ab2535, Cell Signaling) and with an 
anti-mouse FITC-coupled secondary antibody. To reveal biocytin-filled neurons, acute slices 
were fixed with PFA 4% after recording and incubated with Cascade Blue-Neutravidin (A2663, 
Invitrogen). In addition, immunosatining was performed on these slices with a monoclonal 
antibody against choline acetyltransferase (ab35948, Abcam).  
Image acquisition and processing 
Confocal images of immunostained cryosections and acute slices were obtained and processed 
with Image J (Rasband, W.S., NIH, Bethesda, Maryland, USA) to obtain maximum intensity 
projection representations. High resolution images were deconvolved with Huygens (Scientific 
Volume Imaging, Hilversum, The Netherlands). In addition, three-dimensional surface 
renderings were produced with Imaris (Bitplane, Zurich, Switzerland). 
Optogenetics experiments 
ChR2-expresing neurons were activated with a blue laser (473 nm, 100 mW, Rapp-
Optoelectronics) coupled to an optical fiber (200 µm core, Thorlabs). For slice experiments, the 
fiber was attached to a micromanipulator and brought close to the recorded cell. Blue light-
induced photo-currents and action potentials were recorded. For in vivo experiments, the fiber 
was positioned above the NTS of anesthetized mice with a stereotaxic apparatus. Repetitive 
trains of blue light pulses were applied for 40 min. The firing rate of the vagus nerve was 
monitored during the stimulation. Blood glucagon levels were dosed by radioimmunoassay 
shortly after the end of the stimulation.        
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FIGURE LEGENDS 
Figure 1. Glucose Response of Glut2 Neurons in NTS 
(A) Confocal images of Glut2 neurons in NTS showing a cluster of td-Tomato labeled neurons 
(left) and a single neuron patched superimposed with the corresponding infrared DIC image in an 
acute mouse brainstem slice (right). Recording pipette is delineated by white dashed lines. 
(B) Voltage trace from a Glut2 neuron showing a typical accommodating spike train induced by 
depolarizing current injection. 
(C) Agarose gel showing RT-PCR amplification products of Glut2 and control gene β-actin from 
the cytosol of single tdTomato-positive cells aspirated with the recording pipette. Right lane, 
molecular weights marker. 
(D) Left, Vm and Rinput plotted over time in 30 s bins during changes in extracellular glucose 
concentration, in the presence or absence of synaptic inhibitors. Right, representative voltage 
traces at 5mM (black) to 0.5mM (blue) glucose showing the response to the hyperpolarizing 
current steps (sketched below traces) applied to monitor Rinput. See also Figure S1. 
(E) Glucose effect on Vm and Rinput, in the presence (n=13) or absence (n=12) of synaptic 
inhibitors. 
(F) Left, representative voltage traces at 5mM (black) and 0.5mM (blue) glucose showing action 
potential trains elicited by a depolarizing current injection (below). Right, FI curves (n=10) 
obtained at 5mM (black) and 0.5mM glucose (blue). 
(G) Glucose effect on rheobase (n=12) and FI curve gain (n=10), in the presence or absence of 
synaptic inhibitors. 
(H) Changes in membrane potential, input resistance, rheobase, and FI curve gain as a function 
of glucose concentration (n=5). Dashed lines are monoexponential decay fits to the data. 
 
Figure 2. Biophysical Mechanisms of the Glucose-Inhibited Effect  
(A) Left, current-voltage plot showing a reversible inward shift when switching from 5 to 0.5 
mM glucose. Middle, the current-voltage plot of net glucose-induced current (n=12) shows an 
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outward rectification fitted by the GHK current equation (red dashed line). Right, time course of 
net glucose-induced current in response to voltage steps (below). See also Figure S2. 
(B) Voltage trace recorded with high Cl- intracellular solution showing a depolarizing response 
to low glucose. 
(C) Current trace recorded at -70mV with high Cl- intracellular solution and in the presence of 
TTX showing a glucose-induced outward K+ current. 
(D) Glucose effect on Vm (n=11), Rinput (n=11), rheobase (n=9) and FI curve gain (n=9) with 
high Cl- intracellular solution. 
(E) Voltage trace showing the depolarization induced by quinine and its blocking effect on the 
response to changes in glucose concentration. 
(F) Quinine effect on Vm and Rinput (n=6) mimics low glucose and impairs glucose sensing. 
 
Figure 3. Glucose Effect Is Mediated by Cell Metabolism 
(A) Voltage trace showing a partly reversible depolarizing effect of 2-DG in the presence of 
5mM glucose. 
(B) 2-DG effect on Vm and Rinput (n=5) mimics low glucose. 
(C) Voltage trace showing a reversible depolarizing effect of D-glucosamine in the presence of 
5mM glucose. 
(D) D-glucosamine effect on Vm and Rinput (n=7) mimics low glucose. 
(E) Voltage trace showing the response to extracellular glucose when the cell was recorded with 
a glucose-containing intracellular solution (upper trace). In the same cell, adding D-glucosamine 
to the bath induced a depolarization and an increase in Rinput (lower trace). 
(F) Intracellular glucose infusion blunts Vm and Rinput responses to glucoprivation, an effect 
reversed by D-glucosamine (n=7). 
 
Figure 4. Glucose Effect Depends on AMPKinase Activation 
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(A) Voltage trace showing a partly reversible depolarizing effect of oligomycin in the presence 
of 5mM glucose. 
(B) Oligomycin effect on Vm and Rinput (n=7) mimics low glucose. 
(C) Voltage trace showing a depolarizing effect of AICAR in the presence of 5mM glucose. 
(D) AICAR effect on Vm and Rinput (n=7) mimics low glucose. 
(E) Voltage trace showing the blocking effect of compound C on the depolarization induced by 
low glucose. 
(F) Compound C inhibits Vm and Rinput (n=7) responses to low glucose. 
(G) Confocal images of brainstem sections showing the colocalization of AMPK subunit 
pAMPKα immunostaining (green) with tdTomato labeling of Glut2 neurons (red, arrows). 
 
Figure 5. NTS Glut2 Neurons Are GABAergic Cells Projecting to DMNX 
(A-B) Confocal images of brainstem sections showing the colocalization of GABAergic neuron 
marker GAD67 and inhibitory neuron marker parvalbumin (PV) immunostainings (green) with 
tdTomato labeling of Glut2 neurons (red, arrows). 
(C) Left, projection image of a confocal stack of a tdTomato-positive neuron (red, star) patched 
in NTS with a pipette solution containing biocytin. Neutravidin labeling (green) reveals the path 
of the biocytin-filled axon (arrowheads) towards DMNX, which contains ChAT immuno-
positive neurons (purple). Right, 3D rendering of a high resolution image of the area delineated 
with a white dashed line in the left panel, showing axonal boutons in DMNX.  
 
Figure 6. Optogenetic Stimulation of Glut2 Neurons 
(A) IR-DIC and fluorescence image (EYFP) of a Glut2 neuron in the NTS. Scale bar, 10 µm.  
(B) Example firing response (current clamp) and photocurrent (voltage clamp) induced by 
continuous blue light illumination (473 nm). 
(C) Example photocurrents induced by brief pulses (10ms) of blue light of increasing frequencies. 
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(D) Schematic representation of the recording configuration during in vivo optogenetic 
stimulation. 
(E) Vagal firing rate in response to pulsed blue light stimulation (dotted blue line) in ChR2-
expressing mice and their control littermates. 
(F) Blood glucagon levels measured at baseline and at the end the optogenetic stimulation in 
both mice groups. 
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